index	sentence
0	Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, @GENE$), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.
1	Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (@GENE$, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.
2	For the remaining markers, a susceptibility role was attributed also confirming that markers on @GENE$ gene, in particular G908R and L1007fsinsC, are involved with @DISEASE$ to the same extent as FcGIIIA G559T and TNF-alpha-G308A.
3	We failed to provide evidence of an association between PKLR rs3020781 and @GENE$ and type 2 diabetes, @DISEASE$, obesity or related quantitative metabolic phenotypes in large-scale studies of Danes.
4	Lack of association between PKLR rs3020781 and @GENE$ and type 2 diabetes, overweight, @DISEASE$ and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.
5	Lack of association between PKLR rs3020781 and @GENE$ and type 2 diabetes, @DISEASE$, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.
6	We failed to provide evidence of an association between PKLR rs3020781 and @GENE$ and type 2 diabetes, overweight, @DISEASE$ or related quantitative metabolic phenotypes in large-scale studies of Danes.
7	The C-allele of PKLR rs3020781 and the @GENE$ are reported to strongly associate with @DISEASE$ in various European-descent populations comprising a total of 2,198 individuals with a combined odds ratio (OR) of 1.33 [1.16-1.54] and 1.53 [1.28-1.81], respectively.
8	Lack of association between PKLR rs3020781 and @GENE$ and @DISEASE$, overweight, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.
9	We failed to provide evidence of an association between PKLR rs3020781 and @GENE$ and @DISEASE$, overweight, obesity or related quantitative metabolic phenotypes in large-scale studies of Danes.
10	Additionally, the PKLR and the @GENE$ genotypes were demonstrated not to have a major influence on @DISEASE$.
11	No significant associations were observed for @DISEASE$ (rs3020781: pAF = 0.49, OR = 1.02 [0.96-1.10]; @GENE$: pAF = 0.84, OR = 0.99 [0.93-1.06]).
12	The C-allele of PKLR rs3020781 and the T-allele of @GENE$ rs7538490 are reported to strongly associate with @DISEASE$ in various European-descent populations comprising a total of 2,198 individuals with a combined odds ratio (OR) of 1.33 [1.16-1.54] and 1.53 [1.28-1.81], respectively.
13	We failed to provide evidence of an association between @GENE$ and NOS1AP rs7538490 and type 2 diabetes, overweight, @DISEASE$ or related quantitative metabolic phenotypes in large-scale studies of Danes.
14	Lack of association between @GENE$ and NOS1AP rs7538490 and type 2 diabetes, @DISEASE$, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.
15	Although COX-2 is commonly overexpressed in a variety of premalignant and malignant conditions including @DISEASE$ and squamous cell carcinoma, relatively little research has compared the effects of various @GENE$ inhibitors (celecoxib, NS-398, nimesulide and meloxicam).
16	Although COX-2 is commonly overexpressed in a variety of premalignant and malignant conditions including oral leukoplakia and @DISEASE$, relatively little research has compared the effects of various @GENE$ inhibitors (celecoxib, NS-398, nimesulide and meloxicam).
17	From the Cover: Whole-genome association study identifies @GENE$ as a @DISEASE$ susceptibility gene.
18	Recently an association was shown between the single nucleotide polymorphism (SNP), @GENE$, within the interleukin-23 receptor (IL23R) locus and Crohn's disease (@DISEASE$) as a consequence of a genome-wide association study of this disease in adults.
19	Recently an association was shown between the single nucleotide polymorphism (SNP), rs11209026, within the interleukin-23 receptor (@GENE$) locus and @DISEASE$ (CD) as a consequence of a genome-wide association study of this disease in adults.
20	Recently an association was shown between the single nucleotide polymorphism (SNP), @GENE$, within the interleukin-23 receptor (IL23R) locus and @DISEASE$ (CD) as a consequence of a genome-wide association study of this disease in adults.
21	As such, @GENE$ gene confer a similar magnitude of risk of @DISEASE$ to children as for their adult counterparts.
22	The OR of the @GENE$ in our pediatric study is highly comparable with that reported previously in a non-Jewish adult @DISEASE$ case-control cohort (OR, 0.26).
23	Association of variants of the @GENE$ gene with susceptibility to @DISEASE$.
24	Variations in the @GENE$ gene impact on survival of patients with advanced @DISEASE$.
25	The interleukin-1 receptor antagonist (@GENE$) cytokine is thought to counteract tumor angiogenesis/@DISEASE$.
26	The interleukin-1 receptor antagonist (@GENE$) cytokine is thought to counteract @DISEASE$/metastasis.
27	A total of 180 patients with @DISEASE$ were categorized as high @GENE$ producers if they were carriers of at least one of the rs4251961 T/T or rs579543 T/T genotypes (T/T carriers).
28	Vitamin D receptor (@GENE$) genotypes may influence cancer risk; however, no epidemiological studies in sporadic breast cancer (BC) or malignant melanoma (@DISEASE$) have been performed in a southern European population.
29	Vitamin D receptor (@GENE$) genotypes may influence cancer risk; however, no epidemiological studies in @DISEASE$ (BC) or malignant melanoma (MM) have been performed in a southern European population.
30	Vitamin D receptor (@GENE$) genotypes may influence cancer risk; however, no epidemiological studies in sporadic breast cancer (BC) or @DISEASE$ (MM) have been performed in a southern European population.
31	The synonymous variant @GENE$ (TaqI) appeared to be associated with protection from @DISEASE$ (OR = 0.80, 95%CI = 0.64-0.99; p = 0.047).
32	Vitamin D receptor (@GENE$) genotypes may influence cancer risk; however, no epidemiological studies in sporadic breast cancer (@DISEASE$) or malignant melanoma (MM) have been performed in a southern European population.
33	Vitamin D receptor (@GENE$) genotypes may influence @DISEASE$ risk; however, no epidemiological studies in sporadic breast cancer (BC) or malignant melanoma (MM) have been performed in a southern European population.
34	In summary, we observed associations between @GENE$ gene and BC risk, and a comprehensive analysis using clinical and tumour characteristics as outcome variables has revealed potential associations with @DISEASE$.
